Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Susceptibility of Clostridium difficile to LY146032.

× No keyword cloud information.

3 in total

1. In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic.

Authors: G M Eliopoulos; S Willey; E Reiszner; P G Spitzer; G Caputo; R C Moellering
Journal: Antimicrob Agents Chemother Date: 1986-10 Impact factor: 5.191

2. Antibiotic susceptibility of anaerobic bacteria with special reference to Bacteroides fragilis.

Authors: K Dornbusch; C E Nord; B Olsson-Liljeqvist
Journal: Scand J Infect Dis Suppl Date: 1979

Review 3. Aspects on antibacterial treatment of anaerobic infections.

Authors: F Nordbring; C E Nord
Journal: Scand J Infect Dis Suppl Date: 1982

3 in total

4 in total

1. LY146032 treatment of Clostridium difficile colitis in hamsters.

Authors: C E Nord; A Lindmark; I Persson
Journal: Eur J Clin Microbiol Date: 1987-12 Impact factor: 3.267

2. Use of multivariate analysis to compare antimicrobial agents on the basis of in vitro activity data.

Authors: J M Hernández; P Conforti
Journal: Antimicrob Agents Chemother Date: 1994-02 Impact factor: 5.191

3. In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates.

Authors: Ellie J C Goldstein; Diane M Citron; C Vreni Merriam; Yumi A Warren; Kerrin L Tyrrell; Helen T Fernandez
Journal: Antimicrob Agents Chemother Date: 2003-01 Impact factor: 5.191

4. New advances in the treatment of Clostridium difficile infection (CDI).

Authors: Dennis D Hedge; Joe D Strain; Jodi R Heins; Debra K Farver
Journal: Ther Clin Risk Manag Date: 2008-10 Impact factor: 2.423

4 in total